Difference between revisions of "Clopidogrel (Plavix)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
(updated links) |
||
Line 1: | Line 1: | ||
==General information== | ==General information== | ||
− | Class/mechanism: Irreversible thienopyridine class inhibitor of the P2Y<sub>12</sub> class of adenosine diphosphate (ADP) receptors on platelets, inhibiting platelet activation and aggregation.<ref name="insert">[http://products.sanofi.us/PLAVIX/plavix.pdf Clopidogrel (Plavix) package insert]</ref><ref>[[Media:Clopidogrel.pdf | Clopidogrel (Plavix) package insert (locally hosted backup)] | + | Class/mechanism: Irreversible thienopyridine class inhibitor of the P2Y<sub>12</sub> class of adenosine diphosphate (ADP) receptors on platelets, inhibiting platelet activation and aggregation.<ref name="insert">[http://products.sanofi.us/PLAVIX/plavix.pdf Clopidogrel (Plavix) package insert]</ref><ref>[[Media:Clopidogrel.pdf | Clopidogrel (Plavix) package insert (locally hosted backup)]]</ref> |
<br>Route: PO | <br>Route: PO | ||
<br>Extravasation: n/a | <br>Extravasation: n/a | ||
Line 7: | Line 7: | ||
==Patient drug information== | ==Patient drug information== | ||
− | *[http:// | + | *[http://products.sanofi.us/PLAVIX/plavix.pdf Clopidogrel (Plavix) package insert]<ref name="insert"></ref> |
− | + | *[https://packageinserts.bms.com/medguide/medguide_plavix.pdf Clopidogrel (Plavix) medication guide]<ref>[https://packageinserts.bms.com/medguide/medguide_plavix.pdf Clopidogrel (Plavix) medication guide]</ref> | |
*[http://www.uptodate.com/contents/clopidogrel-patient-drug-information Clopidogrel (Plavix) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/clopidogrel-patient-drug-information Clopidogrel (Plavix) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/clopidogrel-patient-drug-information Clopidogrel (Plavix) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/clopidogrel-patient-drug-information Clopidogrel (Plavix) patient drug information (UpToDate)]</ref> | ||
Revision as of 05:31, 20 May 2019
General information
Class/mechanism: Irreversible thienopyridine class inhibitor of the P2Y12 class of adenosine diphosphate (ADP) receptors on platelets, inhibiting platelet activation and aggregation.[1][2]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient drug information
- Clopidogrel (Plavix) package insert[1]
- Clopidogrel (Plavix) medication guide[3]
- Clopidogrel (Plavix) patient drug information (UpToDate)[4]
Also known as
- Brand names: Bio-Clopi, Ceruvin, Clop-75, Clopalvix, Clopicard, Clopidro, Clopinam, Deviplat, Lopigrol, Plagril, Plavix, Stroka